MIRA
MIRA
NASDAQ · Pharmaceuticals

Mira Pharmaceuticals Inc

$0.99
-0.01 (-1.30%)
As of May 9, 9:46 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,233.3% upside
Low Target $12.17
Average Target $23.03
High Target $29.15
Current Price $0.99
Current
$0.99
Target
$23.03
$12.17 $23.03 avg $29.15
Scenario Analysis
Bear Case
$12.17
1,133.0%
Low target
Base Case
$23.03
+2,233.3%
Avg target
Bull Case
$29.15
+2,853.4%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$2.45
-59.7% from high
52-Week Low
$0.90
+9.7% from low
Target vs 52W High
$23.03
+840.0% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%